Dilution, licensing and petlife all discussed in the CC; Link and time marks below
** Petlife specifically is discussed at the beginning of the 3:40 extra continuation of Cc segment that airs immediately after the first segment of the CC - you can find this portion of the CC by simply fast forward to the end of first almost hour long segment and you’ll get to the last 3:40 continuation segment… petlife involvement explained and licensing is further discussed as well ~~~~~~~~~~~~~~~ 41:25 Dilution discussed ** last stage of closing with investors attorney to “avoid future dilution” *** 42:00 investor engaging with FDA LOBBYIST to help FDA process ** investor has experience w distribution of Covid 19 vaccines 42:43 FDA status - discussed “second potential investor” - help to move application from pre Ind to Ind status ~~~~~~~~~~ O:00 petlife (ie at the beginning of 3:40 segment) 1:14 licensing question answer of 3:40 segments) ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Meeting link AND passcode to watch - Topic: Medolife Rx (Quanta, Inc. OTC: QNTA) Investor Conference Call Date: May 12, 2022 04:52 PM Eastern Time (US and Canada)